Home > Node > Subnode Immunopotentiation Cormane, R.H.; Saadawi, A.N.; Asghar, S.S.; Amer, M.A. Journal of the Medical Association of Thailand 70(Suppl 3): 5-81987ISSN/ISBN: 0125-2208 PMID: 3625078 Document Number: 304846 Document emailed within 1 workday Purchase for $29.90 Secure & encrypted paymentsRelated DocumentsKeeling, P.; Winchurch, R.A.; Munster, A.M. 1979: Immunopotentiation following major burn trauma Surgical Forum 30: 50-52Leegaard, J. 1983: Immunosuppression and immunopotentiation in allergic respiratory and lung diseases Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(10): 836-839Maguire, H.C. 1981: Immunopotentiation of allergic contact dermatitis in the guinea pig with C. parvum (P. acnes) Acta Dermato-Venereologica 61(6): 565-567Itoh, O.; Torikai, T.; Satoh, M.; Okumura, O.; Osawa, T. 1981: Immunopotentiation of tumor-bearing and toxohormone treated mice by human ceruloplasmin Gan 72(5): 673-678Goodman, M.G. 1995: A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine Pharmaceutical Biotechnology 6: 581-609Chavali, S.R.; Barton, L.D.; Campbell, J.B. 1988: Immunopotentiation by orally-administered Quillaja saponins: effects in mice vaccinated intraperitoneally against rabies Clinical and Experimental Immunology 74(3): 339-343Hiraoka, A.; Shibata, H.; Masaoka, T. 1992: Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT Transplantation Proceedings 24(6): 3047-3048